Detalhe da pesquisa
1.
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.
Br J Haematol
; 204(4): 1529-1535, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38411250
2.
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis.
Am J Hematol
; 99(4): 755-758, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291566
3.
Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling.
BMC Cancer
; 20(1): 1017, 2020 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087075
4.
The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution.
BMC Cancer
; 19(1): 515, 2019 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142279
5.
Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling.
Clin Epigenetics
; 16(1): 49, 2024 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38549146
6.
AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib.
Cancer Rep (Hoboken)
; 6(10): e1881, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553891
7.
The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas.
Front Oncol
; 13: 1275327, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023160
8.
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis.
Hemasphere
; 7(1): e818, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36570691
9.
Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia.
Front Oncol
; 13: 1302993, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37860185
10.
A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma.
Front Oncol
; 13: 1157646, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188190
11.
Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes.
Hemasphere
; 7(10): e961, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841754
12.
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis.
Front Oncol
; 12: 882531, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35530329
13.
Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model.
Hemasphere
; 6(8): e760, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35935610
14.
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma.
Clin Cancer Res
; 28(12): 2598-2609, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063966
15.
Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia.
Front Oncol
; 12: 968340, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36059646
16.
Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model.
Hemasphere
; 6(4): e706, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392483
17.
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group.
Blood Cancer J
; 12(4): 76, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468898
18.
Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.
PLoS One
; 17(9): e0274984, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107965
19.
Variable Expressivity and Allelic Heterogeneity in Type 2 Familial Partial Lipodystrophy: The p.(Thr528Met) LMNA Variant.
J Clin Med
; 10(7)2021 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33916827
20.
The safety profile of FLT3 inhibitors in the treatment of newly diagnosed or relapsed/refractory acute myeloid leukemia.
Expert Opin Drug Saf
; 20(7): 791-799, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33853481